Immutep Operational Update
Efti clinical trial status updatesExcellent financial position following recent US$7.7 million warrant exercise, with cash runway extended beyond end of...
Day: December 15, 2020
VYNE Therapeutics Announces New U.S. Patent Expiring in 2037 for AMZEEQ® (minocycline) topical foam, 4%
New Granted Patent Listed in FDA’s Orange Book for AMZEEQBRIDGEWATER, N.J., Dec. 15, 2020 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc....
Enzo Biochem Hosting Key Opinion Leader Call on GENFLEX™ Molecular System for COVID-19 and the Role of Testing in a Post-Vaccine Treatment Environment
Thursday, December 17th @ 12:00pmET New York, NY, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a leading...
GT Gain Therapeutics SA Announces Funding from the Swiss Innovation Agency Supporting a 3-year Research Collaboration Project with the Institute for Research in Biomedicine and Neurocentro
- Researchers will further develop the Site-directed Enzyme Enhancement Therapy (SEE-Tx) ™ technology for the treatment of rare genetic and...
Timber Pharmaceuticals Receives Notice of Allowance from U.S. Patent and Trademark Office for Lead Asset TMB-001
- Formal notice confirms intent to grant patent for pharmaceutical isotretinoin composition - WOODCLIFF LAKE, N.J., Dec. 15, 2020 (GLOBE...
GBT Announces New Employment Inducement Grants
SOUTH SAN FRANCISCO, Calif., Dec. 15, 2020 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that on December...
Applied Therapeutics to be Added to NASDAQ Biotechnology Index
NEW YORK, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline...
SeaSpine Announces FDA 510(k) Clearance for Amended Indication for NanoMetalene® Surface Technology
CARLSBAD, Calif., Dec. 15, 2020 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on...
Amedisys Welcomes New Board Member
Ivanetta Davis Samuels Joins Board of DirectorsBATON ROUGE, La., Dec. 15, 2020 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading...
Kiniksa Commences Dosing of Vixarelimab Phase 2b Clinical Trial in Prurigo Nodularis
– Evaluating vixarelimab across a range of once-monthly dose regimens injected subcutaneously –HAMILTON, Bermuda, Dec. 15, 2020 (GLOBE NEWSWIRE) --...
Larimar Therapeutics Added to NASDAQ Biotechnology Index
BALA CYNWYD, Pa., Dec. 15, 2020 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused...
Sensus Healthcare Engages Ekpac Healthcare Ltd. as New Exclusive Distributor in China for SRT-100™ Systems
Agreement is for the treatment of non-melanoma skin cancer and keloids, covers China and Hong Kong and is effective January...
Fortress Biotech Announces Breakthrough Therapy Designation for CUTX-101, Copper Histidinate, for the Treatment of Menkes Disease
Rolling submission of New Drug Application to the FDA for CUTX-101 on track to begin in the first quarter of...
Avadel Pharmaceuticals Added to NASDAQ Biotechnology Index
DUBLIN, Ireland, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218, an investigational,...
Karamedica Announces National Institute on Aging Grant to Continue Development of Microparticle Therapy for Cerebral Amyloid Angiopathy
RALEIGH, N.C., Dec. 15, 2020 (GLOBE NEWSWIRE) -- Karamedica, Inc. recently received a $2.5 million Small Business Innovative Research (SBIR)...
RECELL® System Data Presented at American Burn Association Fall Regional Burn Conferences
Abstracts Highlighting Clinical and Health Economic Data Reinforce Effectiveness of Treatment with RECELL System More than 10,000 Patients treated with RECELL...
Aleafia Health Enters Supply Agreement with Cannabis Brand House BLLRDR
Afghani Bullrider Rare cultivars. Aleafia Health subsidiary Emblem to exclusively distribute BLLRDR products in medical channelInitial launch to feature rare...
Plus Therapeutics Completes Sixth Dosing Cohort in ReSPECT™ Glioblastoma Trial
AUSTIN, Texas, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing novel,...
Havn Life Sciences announces $5 million Bought Deal Financing
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Dec. 15, 2020...
Mydecine Innovations Group Engages the ProPharma Group to Proceed with FDA Filings and Approval for Novel Research and Multiple Phase Clinical Trials
Leading FDA consultancy firm to advise on drug development and clinical trial pipelineDENVER, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Mydecine...